Literature DB >> 27195189

The progress of early growth response factor 1 and leukemia.

Jing Tian1, Ziwei Li1, Yang Han1, Tao Jiang2, Xiaoming Song3, Guosheng Jiang1.   

Abstract

Early growth response gene-1 (EGR1) widely exists in the cell nucleus of such as, zebrafish, mice, chimpanzees and humans, an it also can be observed in the cytoplasm of some tumors. EGR1 was named just after its brief and rapid expression of different stimuli. Accumulating studies have extensively demonstrated that the widespread dysregulation of EGR1 is involved in hematological malignancies such as human acute myeloid leukemia (AML), chronic myelogenous leukemia, chronic lymphocytic leukemia, multiple myeloma, and B cell lymphoma. With the deep research on EGR1, its expression, function and regulatory mechanism has been gradually elucidated, and provides more possibilities for treatment strategies of patients with leukemia. Herein, we summarize the roles of EGR1 in its biological function and relationship with leukemia.

Entities:  

Keywords:  Early growth response gene-1 (EGR1); acute myeloid leukemia; tumor

Year:  2016        PMID: 27195189      PMCID: PMC4869586          DOI: 10.5582/irdr.2015.01049

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  100 in total

1.  A novel t(5;11)(q31;p15) involving the NUP98 gene on 11p15 is associated with a loss of the EGR1 gene on 5q31 in a patient with acute myeloid leukemia.

Authors:  Yong Wang; Yongquan Xue; Suning Chen; Yafang Wu; Jinlan Pan; Jun Zhang; Juan Shen
Journal:  Cancer Genet Cytogenet       Date:  2010-05

2.  p130Cas acts as survival factor during PMA-induced apoptosis in HL-60 promyelocytic leukemia cells.

Authors:  Joerg Kumbrink; Kathrin H Kirsch
Journal:  Int J Biochem Cell Biol       Date:  2012-12-31       Impact factor: 5.085

3.  Opposite effects of inhibitors of mitogen-activated protein kinase pathways on the egr-1 and beta-globin expression in erythropoietin-responsive murine erythroleukemia cells.

Authors:  András Schaefer; Ferenc Kósa; Thomas Bittorf; Mária Magócsi; Anette Rosche; Yoandra Ramirez-Chávez; Stefan Marotzki; Hans Marquardt
Journal:  Cell Signal       Date:  2004-02       Impact factor: 4.315

Review 4.  Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications.

Authors:  Andrzej S Tarnawski; Michael K Jones
Journal:  J Mol Med (Berl)       Date:  2003-09-06       Impact factor: 4.599

5.  The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML.

Authors:  Florian H Heidel; Lars Bullinger; Patricia Arreba-Tutusaus; Zhu Wang; Julia Gaebel; Carsten Hirt; Dietger Niederwieser; Steven W Lane; Konstanze Döhner; Valera Vasioukhin; Thomas Fischer; Scott A Armstrong
Journal:  J Exp Med       Date:  2012-12-31       Impact factor: 14.307

6.  Early Growth Response-1 Plays a Non-redundant Role in the Differentiation of B Cells into Plasma Cells.

Authors:  Yeon-Kyung Oh; Eunkyeong Jang; Doo-Jin Paik; Jeehee Youn
Journal:  Immune Netw       Date:  2015-06-25       Impact factor: 6.303

7.  Nanopore sensing of individual transcription factors bound to DNA.

Authors:  Allison Squires; Evrim Atas; Amit Meller
Journal:  Sci Rep       Date:  2015-06-25       Impact factor: 4.379

8.  Bone marrow-derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion-induced lung injury.

Authors:  Jing Li; Jian Zhou; Dan Zhang; Yuanlin Song; Jun She; Chunxue Bai
Journal:  J Cell Mol Med       Date:  2015-07-14       Impact factor: 5.310

9.  Identification of apoptosis-related microRNAs and their target genes in myocardial infarction post-transplantation with skeletal myoblasts.

Authors:  Qi Liu; Guo Qing Du; Zhi Tao Zhu; ChunYang Zhang; Xiao Wei Sun; Jing Jin Liu; Xia Li; Yong Shun Wang; Wen Juan Du
Journal:  J Transl Med       Date:  2015-08-19       Impact factor: 5.531

10.  Discovering transcription and splicing networks in myelodysplastic syndromes.

Authors:  Hongyan Wang; Jianguo Wen; Chung-Che Chang; Xiaobo Zhou
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more
  9 in total

Review 1.  Ca2+ as a therapeutic target in cancer.

Authors:  Scott Gross; Pranava Mallu; Hinal Joshi; Bryant Schultz; Christina Go; Jonathan Soboloff
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

2.  Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling.

Authors:  Sujitha Duggimpudi; Andreas Kloetgen; Sathish Kumar Maney; Philipp C Münch; Kebria Hezaveh; Hamed Shaykhalishahi; Wolfgang Hoyer; Alice C McHardy; Philipp A Lang; Arndt Borkhardt; Jessica I Hoell
Journal:  J Biol Chem       Date:  2018-08-20       Impact factor: 5.157

3.  miR-let-7c-3p targeting on Egr-1 contributes to the committed differentiation of leukemia cells into monocyte/macrophages.

Authors:  Fu Qi; Xinping Wang; Shouzhen Zhao; Chaozhe Wang; Ruijing Sun; Huan Wang; Pengchao Du; Jing Wang; Xidi Wang; Guosheng Jiang
Journal:  Oncol Lett       Date:  2022-06-22       Impact factor: 3.111

4.  Dynamical modeling predicts an inflammation-inducible CXCR7+ B cell precursor with potential implications in lymphoid blockage pathologies.

Authors:  Jennifer Enciso; Luis Mendoza; Elena R Álvarez-Buylla; Rosana Pelayo
Journal:  PeerJ       Date:  2020-09-29       Impact factor: 2.984

5.  Matrix factorization and transfer learning uncover regulatory biology across multiple single-cell ATAC-seq data sets.

Authors:  Rossin Erbe; Michael D Kessler; Alexander V Favorov; Hariharan Easwaran; Daria A Gaykalova; Elana J Fertig
Journal:  Nucleic Acids Res       Date:  2020-07-09       Impact factor: 16.971

6.  EGR1 Addiction in Diffuse Large B-cell Lymphoma.

Authors:  Shuichi Kimpara; Li Lu; Nguyet M Hoang; Fen Zhu; Paul D Bates; Anusara Daenthanasanmak; Shanxiang Zhang; David T Yang; Amanda Kelm; Yunxia Liu; Yangguang Li; Alexander Rosiejka; Apoorv Kondapelli; Samantha Bebel; Madelyn Chen; Thomas A Waldmann; Christian M Capitini; Lixin Rui
Journal:  Mol Cancer Res       Date:  2021-05-12       Impact factor: 5.852

7.  CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition.

Authors:  Mauro Rosales; Arielis Rodríguez-Ulloa; George V Pérez; Vladimir Besada; Thalia Soto; Yassel Ramos; Luis J González; Katharina Zettl; Jacek R Wiśniewski; Ke Yang; Yasser Perera; Silvio E Perea
Journal:  Front Mol Biosci       Date:  2022-03-11

8.  Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter.

Authors:  Dian-Gang Chen; Bo Zhu; Sheng-Qing Lv; Hongfan Zhu; Jinliang Tang; Changlin Huang; Qingrui Li; Pu Zhou; Dong-Lin Wang; Guang-Hui Li
Journal:  J Exp Clin Cancer Res       Date:  2017-12-15

9.  Nobiletin Promotes Megakaryocytic Differentiation through the MAPK/ERK-Dependent EGR1 Expression and Exerts Anti-Leukemic Effects in Human Chronic Myeloid Leukemia (CML) K562 Cells.

Authors:  Jui-Hung Yen; Ching-Yen Lin; Chin-Hsien Chuang; Hsien-Kuo Chin; Ming-Jiuan Wu; Pei-Yi Chen
Journal:  Cells       Date:  2020-04-03       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.